Key Points • EVI1 exerts distinct roles in AML, including resistance, pathogenicity of aggressive diseases independent of stemness, and immune evasion.• ERG and cyclin D1 are leukemia-specific targets of EVI1,… Click to show full abstract
Key Points • EVI1 exerts distinct roles in AML, including resistance, pathogenicity of aggressive diseases independent of stemness, and immune evasion.• ERG and cyclin D1 are leukemia-specific targets of EVI1, providing potential therapeutic vulnerability of EVI1-associated AML.
               
Click one of the above tabs to view related content.